Speakers
Default
Mark Skylar-Scott
Associate Professor
Stanford University
Marlin Frechette
Chief Compliance & Quality Officer
FUJIFILM Irvine Scientific
Syed Reza
External Innovation and Partnering
NOF America
Tamika Jackson
Relations Director
Bullpen
Taryn Aubrecht
Program Director Clinical and Research Tools
NIH
Therese Choquette
Head of Analytical & Translational Sciences
Tigen
Tony Ting
CSO
Kiji Therapeutics
Troels Jordansen
Executive Chairman
KELI Therapeutics
Yosuke Kurokawa
Senior Scientist II
FUJIFILM Irvine Scientific
Luc Henry
CEO and Co-founder
Limula SA
Lisa O' Flynn
VP, Process & Analytical Development
Avectas
Martin Kessler
CEO
DINAMIQS
Michael Sweeney
Global Head of Strategy (CGT & DTP)
QuickStat
Michalle Adkins
Director, Life Sciences Marketing and Strategy
Emerson Automation Solutions
Micheala Jones
Lead, Global Medical Affairs, Hemophilia Gene Editing (CRISPR/Cas9) and Thrombosis
Regeneron
Mike Dybicz
Senior Vice President and Chief Product Development Officer
Cryoport Systems
Mike Hughson
Head of Business Development
Cytomos
Nikki Bishop
VP Marketing Life Sciences
EMERSON AUTOMATION SOLUTIONS
Peter Anderson
Chief Research Officer
TREEFROG THERAPEUTICS
Priya Baraniak, Ph.D.
Allogeneic Cell Therapy Expert & formerly Chief Business Officer
Formerly OrganaBio
Raymond Luke
Director, MSAT
Verismo Therapeutics
Rutvi Sanghavi
Manager, Lead Researcher
Sekisui America Corporation
Saeed Alturki
Executive Director, National Priorities and Missions Sector
Research, Development & Innovation Authority (RIDA)
Sarah Creviston
Global Vice President, Patient Advocacy and Public Affairs
Novartis Gene Therapies
Sarah Hein
Chief Executive Officer
March Biosciences
Sarah Snykers
Head of Operations
Legend Biotech
Simon Baker
Co-Founder
PQP Group
Steven Feldman
Site Head and Scientific Director
Stanford School of Medicine
Stuart Lowe
Head of Biotech, Cell & Gene
TTP plc
Suzanne Snellenberg
Vice President, Cell Line Development
Cellistic
